GT Medical Technologies
Develops bioresorbable radiotherapy implants for surgical treatment of operable brain tumors
$100MSeries E
Role not disclosedLoading investors…
Activity from announced rounds
Develops bioresorbable radiotherapy implants for surgical treatment of operable brain tumors
Develops first- and best-in-class antibody-drug conjugates (ADCs) for cancer treatment
Develops thrombectomy systems for venous thromboembolism treatment
Provides digital treatments for insomnia, anxiety, and depression
Pitching Gilde Healthcare? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room